Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity

Abstract

Decreased NMF is a global feature of moderate-to-severe AD; within AD, FLG genotype is the major determinant of NMF, with disease severity as a secondary modifier. NMF components are reliably determined by a noninvasive and relatively inexpensive tape stripping technique.